Abstract The prevalence of autism spectrum disorders (ASDs) is currently estimated at 1 in 68 individuals in the US (Centers for Disease Control and Prevention (Morb Mortal Wkly Rep 63:1-21, 2014)), and recommendations for screening and best practices for diagnostic evaluations have been formulated in scientific, clinical, and institutional venues, if not successfully implemented. As such, this article reviews the best practices in the field for toddler, school-age and adolescent/adult assessments, describes at-risk symptomatology in toddlers, reviews common co-morbidities to be aware of at each time point, discusses cultural issues with regard to diagnoses, and brings forth new research, particularly with regard to earlier screening and diagnosis.
Introduction
Assessment of autism spectrum disorders (ASDs) is a slowly changing landscape. Over the past decade, new screening and early detection methods have come into play, pushing for earlier identification and making the ascertainment of 'at-risk' symptomatology increasingly important. When considering the importance of making a diagnosis of ASD, the label provides access to services, resources, and a common language that parents and individuals can use in order to better understand and navigate their landscape. Early diagnosis also leads to earlier intervention, which results in a better prognosis for the child [2•, 3, 4, 5•] . Earlier intervention may also prevent associated symptomatology such as aggression, behavioral dysregulation, anxiety and depression [6] [7] [8] , may reduce family stressors [9, 10] , and also reduce societal costs [11] [12] [13] . As a result, an increasing number of tools have been developed to identify and screen for the disorder. This article provides an overview of the current state of comprehensive evaluations for individuals with, and at risk for, ASD throughout the lifespan, and describes the continued strive for identification as young as possible.
Changes with the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) [14] provides standardized criteria that are used by clinicians to diagnose ASDs. Since publication of the DSM 4th edition, text revision (DSM-IV-TR), criteria have moved from three distinct symptom categories to a two-category system, with a more dimensional approach to conceptualizing the spectrum (i.e. rather than having distinct subtypes) [15] . In the DSM-5, Criteria A include deficits in social communication and social interaction, and Criteria B include restricted and repetitive patterns of behavior. Specifiers can indicate the presence of intellectual and/or language impairment, as well as symptom severity. Studies comparing the DSM-IV-TR and DSM-5 classifications show that most individuals who were diagnosed with a pervasive developmental disorder, as per the DSM-IV, also meet the criteria for ASD, as per the DSM-5. However, some studies question whether the DSM-5 accurately ascertains individuals with higher functioning ASD (i.e. without comorbid cognitive impairment) [16] [17] [18] .
Early Screening and Detection

Clinical Assessment Measures
Given that autism can be reliably diagnosed by experienced clinicians by the age of 2 years [19] , and that parents typically express concern about their child's development as early as 12 months of age [20] [21] [22] , it is astonishing that the average age of diagnosis in the US continues to be well over 4½years [23] . Moreover, despite the fact that the American Academy of Pediatrics (AAP) currently recommends developmental surveillance and screening for ASD at 18 and 24 months [24] , only 28 % of primary care providers routinely use an ASD-specific screening tool [25] . Additionally, when effective screeners are utilized (e.g. the Modified Checklist for Autism in Toddlers, Revised with Follow-up [M-CHAT-R/ F]), only 62 % of children who screened positive followed through with referrals for diagnostic evaluations [26] . Barriers include lack of time to screen and lack of familiarity with screening tools.
Numerous screeners for ASDs are used both clinically and scientifically to identify at-risk infants and toddlers, with the goal being to detect the need for further evaluation rather than to diagnose. The first screening attempt, the Checklist for Autism in Toddlers (CHAT) [27] , was developed in the UK in 1992. An elaboration on CHAT-the M-CHAT and the new M-CHAT-R/F-is a similar but extended 23-item parent report checklist that is currently the most commonly used screener for ASDs in primary care settings. Success with the M-CHAT-R/F has shown a reduction in diagnosis of 2 years [26] .
The Infant-Toddler Checklist (ITC) [22] is a 24-item parent questionnaire designed to screen for communication delays in children aged 6-24 months. Although it was developed as a broadband screener for general communication delays, it has been validated as a screener for ASDs in children aged 9-24 months [22] . The most predictive items of the ITC have been used to modify the ITC into an ASD-specific screener known as the Early Screener for Autism and Communication Disorders (ESAC) [28] , with validation studies underway.
Several other screening tools include the Early Screening of Autism Traits questionnaire (ESAT) [29] , the InfantToddler Social and Emotional Assessment (ITSEA) [30] , and the Brief Infant-Toddler Social and Emotional Assessment (BITSEA) [31] . The Screening Tool for Autism in 2-year-olds (STAT) [32, 33] is a more interactive measure developed to screen for autism in children aged between 24 and 36 months. It was designed for use by community service providers who work with young children in assessment or intervention settings and who have experience with autism. It consists of 12 items and takes about 20 min to administer.
To address some of the limitations of screening tools, Barbaro and Dissanayake [34, 35] studied the effectiveness of a developmental surveillance program where they had maternal and child health nurses and related practitioners assessing children at 8, 12, 18, and 24 months for early markers of ASDs, prospectively in a community-based setting. Overall, it was found that when following children prospectively over time, sensitivity, specificity, and positive predictive values were high. Using this approach resulted in earlier identification of children with ASD, as well as the ability to ascertain children with milder symptomatology that otherwise might have been missed.
Although packaged screeners are easy and efficient, research is showing that patterns in developmental profiles that are detected by direct assessment are also predictive of ASD. For instance, delays and deviance in postural and motor development have been linked to ASD in high-risk infants, such as delays in sitting and standing, as well as in the initiation of changes in posture [36] . Item-analyses of the Autism Diagnostic Observation Schedule, 2nd edition, Toddler Module (ADOS-T) [37] show that a combination of limited requesting, imitation skills, and showing behaviors in 12-month-old high-risk infants are predictive of later ASD [38] . Studies also suggest that multiple pathways leading to ASD could exist, with varying profiles of vulnerabilities to observe for [38, 39] . These findings highlight the need for comprehensive evaluations that include direct testing of infants at risk and at multiple time points in early development.
Experimental Measures
As behavioral measures continue to be used for the early detection of ASD, experimental technologies are also proving effective in detecting the first signs of ASD-some even before behavioral features are clinically observed.
Several studies have involved eye-tracking paradigms to detect ASD. For instance, using eye-tracking methodologies, Jones and Klin [40•] found that high-risk infants (by nature of having an older biological sibling with ASD) who were later diagnosed with ASD themselves have a significant decline in eye fixation between 2 and 6 months of age. The rate of decline during this period of infancy was found to be more predictive of future autism than even the diagnostic measures themselves. In a similar cohort of infants, Shic and colleagues [41] found that eye gaze to faces decreased in infants later diagnosed with ASD only when the presented face was speaking. In a study on older toddlers with ASD between the ages of 14 and 42 months, Pierce and colleagues [42] examined the preference of looking at social images compared with geometric shapes, and found that toddlers with ASD preferred the geometric images significantly more than toddlers without ASD.
Neuroimaging studies are also showing early brain abnormalities in high-risk infants. For instance, aberrant development of white matter fiber tracks has been found between the ages of 6 and 24 months in infants later diagnosed with ASD [43•] . Furthermore, these abnormalities have been found to precede and subsequently predict early non-verbal social communication deficits in ASD, such as joint attention [44] .
The largest body of literature in the field of autism is focused on genetics. Currently, there is such a strong genetic basis for autism (upwards of 30-40 % of ASD cases yield positive genetic findings) that the American College of Medical Genetics and Genomics Practice Guidelines recommend discussing the need for genetics testing for all individuals with ASD [45] . Despite these incredible strides, efforts to identify specific biomarkers of ASD are still in the preliminary stages. As such, the potential implications on parents to make decisions regarding family planning raise important bioethical questions that need to be further studied [46] . Nevertheless, practitioners need to be well informed of these issues so that they can help families cope with diagnostic information and effectively navigate options for care-which has resulted in an increased need for genetics counseling in the field [47] .
Comprehensive Developmental Evaluations
While screeners often rely heavily on parent report, a comprehensive evaluation should also include direct observation and interaction with the child. The gold-standard assessment is the Autism Diagnostic Observation Schedule, 2nd edition (ADOS) [37, 48] , which includes five different modules based on age and language level. The ADOS takes about 45 min to administer and places the child in naturalistic social situations that elicit specific social and communicative reactions. The Toddler Module [37] can be conducted in children aged 12-30 months. For younger infants, the Autism Observation Scale for Infants (AOSI) [49] can be used between 6 and 18 months.
An additional critical component to any diagnostic evaluation is conducting a thorough developmental history. This entails inquiring about pregnancy, pre-, peri-and postnatal delivery, early developmental milestones, feeding, sleep, and behavioral patterns, and medical and family history. The most comprehensive measure that assesses for historical patterns of behavior pertinent to ASD is the Autism Diagnostic Interview-Revised (ADI-R) [50] , a semi-structured interview that is keyed into the DSM-IV diagnostic criteria for autism. Due to the lengthy nature of the interview and in-depth training required to code each item, the ADI-R is often limited to research use. In fact, the ADI-R [50] and ADOS [51] are used in fewer than 0.1 % and 2.1 %, respectively, of diagnostic evaluations for ASD [52] . Lesser quality (i.e. inferior to the gold-standard instruments) instruments, such as parent questionnaires and checklists, are used in only 30 % of such evaluations [52] , while the remainder of diagnostic evaluations for ASD-more than 67 % of all such evaluations-use no standardized or validated instruments. The usage of goldstandard instruments is confined to specialty clinics with limited patient capacity.
Best-practice guidelines for comprehensive diagnostic evaluation also call for standardized assessments of the child's cognitive functioning, adaptive, and language skills [53] , regardless of the age at which they present for the evaluation. Profiles of strengths and weaknesses are imperative, both to inform the diagnosis and to make appropriate treatment and intervention recommendations. For children with ASD, the clinical presentation is striking in regard to variable profiles both within and across domains, as well as throughout the course of life. It is thus essential to evaluate profiles of behaviors across the lifespan, particularly at pivotal stages of development. With each age group there are important things to consider in undertaking a diagnostic evaluation. These are described in the sections below.
Infants and Toddlers
In younger children, it is important to assess for the absence of or delay in developmental milestones that would be expected at a given age, along with the emergence of autism symptomatology. To assess developmental profiles, the Mullen Scales of Early Learning [54] and the Bayley Scales of Infant Development, 3rd edition [55] are the most commonly used instruments that typically evaluate areas of receptive and expressive language, fine and gross motor skills, and conceptual or nonverbal reasoning. For evaluating speech, language, and communication in young children, there are a host of instruments, including the Communication and Symbolic Behavior Scales, Developmental Profile (CSBS-DP) [56] , which specifically assesses social communication and symbolic play skills for children aged between 6 and 24 months, and the Preschool Language Scale, 5th edition (PLS-5) [57] , which measures auditory comprehension and expressive communication from birth through 7 years 11 months. All instruments generally provide an overall standard score that gives a general picture of a child's abilities, along with subdomain scores that elucidate specific strengths and weaknesses.
At-risk behaviors for ASD in infancy include the absence of joint attention, pointing, and gaze following. These behaviors usually develop between 9 and 14 months of age in typical development and thus are only of concern when they have not appeared after this age [58] . If a child exhibits developmental and/or speech delays, the absence or delays in social communication need to be considered in line with mental age. A recent study highlighted several behavioral features that are more likely to indicate the need for autismspecific intervention [59•] . These include visual peering/ examination of objects or clutching objects in their hands for extended periods of time, and not sharing their interest in these objects with others. At-risk non-verbal communication skills include limited showing, pointing and responding to name, and limited range and frequency of eye gaze, gesture, and facial expressions. Limited vocalizations (e.g. babbling or jabbering) certainly raise concern, particularly if the vocalizations are not directed at, and reciprocal with, another person, and if they are not well integrated with eye gaze, gestures, and facial expressions.
An additional standard component of a diagnostic evaluation is the assessment of adaptive or 'real-life' skills. Measures of adaptive functioning, such as the Vineland Adaptive Behavior Scales, 2nd edition (Vineland-II) [60] , or the Adaptive Behavior Assessment System, 2nd edition (ABAS-II) [61] , generally examine functional communication, socialization, daily living, and motor skills. Research has repeatedly shown that individuals with ASD have significant challenges in successfully translating their repertoire of conceptual/ language skills to functional, daily routines (e.g. Klin et al. [62] and Kanne et al. [63] ) and that deficits in adaptive skills-particularly in socialization-can be evident in children with ASD as early as 2 years of age (e.g. Paul et al. [64] and Ventola et al. [65] .
ASDs are associated with highly variable levels of language, developmental, and conceptual functioning that span from severely delayed and/or non-verbal to intellectually gifted and/or verbally precocious. This variability increases the challenge of early identification, particularly in making differential diagnoses between language and/or developmental delays and ASD, and between ASD and the social vulnerabilities that come with precocious development. Oftentimes, there is a need for giving a provisional diagnosis of ASD in infants and toddlers that requires close monitoring and re-evaluation over time.
School-Age Children
Autism symptomatology in school-age children tends to be more readily identifiable than in young childhood as the gap between age and social difficulties has typically widened, such that parents, teachers, and others who are involved in the day-to-day life of the child are overtly concerned. Evaluations continue to involve assessment of a child's speech, language, communication, social, intellectual, behavioral, and adaptive functioning, both through direct testing and gathering of developmental and present educational history. In addition, other components of an evaluation might be necessary in order to rule out potential learning disabilities, attentional disabilities, difficulties with executive functioning, behavioral challenges, and the like. A skilled clinician should evaluate the child and make assessment decisions as necessary as an evaluation proceeds.
School-age individuals with ASD can also exhibit an increase in learning difficulties, behavioral regulation, and emotional symptomatology. Learning challenges tend to become most apparent as children segue from rote, concrete learning to more conceptual and abstract learning. Common comorbidities include hyperlexia, non-verbal learning disability, or specific learning disorders (e.g. mathematics, written expression). Behavioral challenges (e.g. aggression, tantrums, melt-downs, self-injury) typically emerge as the result of an inability to effectively communicate one's needs and wants, making it imperative to conduct functional behavior assessments to identify behavioral triggers and subsequently teach more functional skills. Anxiety tends to be markedly common as individuals with ASD struggle to navigate an extremely social world (e.g. having to tolerate transitions, changes in routines, social demands, etc.). They can also have atypical reactions to environmental stimuli (e.g. specific fears and phobias, obsessive compulsive behaviors, generalized anxiety). Psychotropic medications can be effective in alleviating these symptoms [66] . In the absence of treatment, these challenges can set-up individuals with ASD for failed experiences that may result in depressive symptoms and even suicidality, particularly during the later school-age years and into adolescence and adulthood [67] .
Difficulties with attention, hyperactivity, and emotion regulation are also commonly observed in school-aged individuals with ASD. On standardized rating scales, at least onethird of individuals with ASD also meet the criteria for a diagnosis of attention-deficit hyperactivity disorder (ADHD) [68, 69] . On assessments of disruptive behavior, research has found that up to 60 % of individuals show self-injurious, aggressive, oppositional, disruptive, and destructive behaviors [70] [71] [72] . Importantly, there are a subset of individuals who exhibit behaviors that pose more serious safety concerns, including elopement, self-injury, and pica [73] [74] [75] [76] .
The DSM-5 now stipulates that individuals with ASD can carry a dual diagnosis of ASD and ADHD. Thus, this comorbid diagnosis signifies that the symptoms of inattention, impulsivity, and/or hyperactivity are above and beyond what would be expected for ASD, and that specific intervention strategies to address these comorbid behaviors could be indicated.
Adolescents and Adults
Despite the fact that ASD is a neurodevelopmental disorder that emerges in the first few years of life, and despite the strides made in early detection and identification of the disorder, many adults remain unidentified as having ASD and/or they have been misidentified with other diagnostic labels throughout their childhood. However, requests for adolescent/adult evaluations can also revolve around addressing a specific need or providing updated information for continued services (e.g. transition to adulthood, planning for college or post-secondary education, identifying legal guardianship post-age of majority, eligibility for state services, etc.).
Current research shows that the majority of individuals with ASD have intellectual abilities in the average to aboveaverage range [1••] and should therefore have the capacity to be independent adults. However, research on adult outcome in ASD indicates that more than 50 % of adults fail to achieve levels of independent employment, living, and self-care, and fail to establish meaningful social relationships [77] [78] [79] . They may possess the skills to perform a job successfully but they get into trouble in the work or community environment which demands a modicum of social ability to successfully navigate. Moreover, adolescents and adults with ASD can be vulnerable to being victimized due to their social naiveté and limited insight into, or awareness of, social nuances. For example, they might not be aware of solicitations (in person or via the Internet); they may not comprehend sarcasm, figures of speech, or teasing; and they could have inappropriate circumscribed or restricted interests that get them into legal trouble. For these reasons, it becomes all the more imperative to include assessments of adaptive functioning and social/ emotional awareness into the diagnostic evaluation process, and to ensure that strategies to enhance functional social and daily life skills are explicitly taught.
Consistent with school-age and adolescent individuals, research has shown high rates of comorbid conditions, including anxiety disorders, depressive disorders, and ADHD in adults with ASD [80] . Previous studies have shown that between 11 and 30 % of adolescents with ASD also meet the criteria for major depressive disorders [81] [82] [83] , and estimates of comorbid anxiety disorders range from 43 to 84 % [81, [83] [84] [85] . While schizophrenia and autism are two distinct disorders, there is also a subset of individuals with autism who begin to demonstrate psychotic symptoms in adolescence or early adulthood [86] , although the true rate of comorbid psychosis is difficult to establish, for a couple of reasons. First, there is some symptom overlap, particularly between autism and the prodromal state of schizophrenia, which involves worsening symptoms of social withdrawal, poor eye contact, and communication difficulties [87] . Second, common ASD symptoms of rigidity and difficulty shifting set can be misinterpreted as paranoia and thought disorder, sometimes resulting in a misdiagnosis of schizophrenia in individuals with autism [88] (see also Hofvander et al. [80] and Raja and Azzoni [89] ). Thus, to correctly distinguish ASD from emerging thought disorder, or to determine if both conditions are co-occurring, it is particularly important to learn as much as possible regarding early developmental history and the developmental course of symptoms over time.
Recent studies have also highlighted comorbid catatonia syndrome in individuals with ASD [90] . The DSM-5 reflects a wider view of catatonia as a condition that is not only associated with schizophrenia but one that can also occur with other psychiatric and medical conditions. Wing and Shah [91] found that individuals with co-occurring ASD and catatonia showed particular characteristic symptoms, such as difficulty initiating movements, increased passivity, a worsening of ritualistic and repetitive behaviors, and the reversal of day and night. While it is now recognized that catatonia can co-occur with ASD, there are also many symptoms of catatonia that can be misinterpreted as ASD symptoms, including mutism, stereotypic speech, repetitive behaviors, echolalia, posturing, mannerisms, purposeless agitation, and rigidity [90] . Again, obtaining a good understanding of the age of onset and course of these symptoms is critical for making the differential diagnosis between these two conditions, as well as determining whether they are comorbid conditions.
Cultural Disparities in Assessment and Diagnosis of Autism Spectrum Disorders
As noted previously, the enormous variability in human development contributes to the large heterogeneity in ASD symptomatology. Given the fact that current diagnosis does not come from biological or genetic assessments but from interpretative clinical judgment based on observation and a developmental history review, healthcare practices, as well as cultural differences between families and providers, may also have an influence on assessment and characterization.
No significant differences in ASD symptomatology related to social deficits have been reported when comparing individuals from different countries [92] or different groups within a country [93•] . However, differences do exist in overall identification and level of cognitive functioning. There is a higher prevalence of ASD in White individuals compared with other racial and ethnic groups in the US [1••, 94, 95] . According to recent studies, these differences do not always translate into group differences in the age of diagnosis [1••, 96 •], highlighting that misdiagnosis or lack of diagnosis in minorities is even a greater problem than delayed identification.
Racial and ethnic differences in the US mostly affect children without cognitive delays [1••, 97] from families with a lower socioeconomic status [98•], i.e. there are no racial/ ethnic differences in higher socioeconomic strata and no differences in prevalence of ASD with co-occurring cognitive delays. Therefore, ASD with intellectual disabilities accounts for most of the ASD diagnoses in racial/ethnic minorities [93•, 97, 99] . Finally, there is also a well-documented association between socioeconomic status and higher prevalence and lower age of diagnosis in the US [97, 100, 101] , with children from geographical areas comprised of adults with higher education and family incomes being diagnosed more frequently and earlier. Again, this association only holds for children without cognitive delays [98] . The direction of the socioeconomic gradient for ASD identification is the opposite in other countries such as Sweden that have nearly universal access to healthcare, where prevalence of ASD (but also ASD with co-occurring cognitive delays) is higher in immigrant populations [102] .
In most developmental conditions the greatest source of differences is socioeconomic rather than racial or ethnic [103] , and ASD seems to be no different. It remains a distinct condition, with a strong genetic component and probably universal symptomatology related to social functioning. However, factors such as family income, maternal education, rural/ urban origin, and immigration status, as well as their interaction with associated features such as cognitive functioning, cannot be ignored in the assessment of ASD throughout the lifespan, nor the fact that there are indeed racial/ethnic disparities in lower socioeconomic strata, at least in the US. In addition to public health efforts to make services more accessible for all, and relevant to this paper, the socioeconomic sensitivity of assessment instruments and the cultural competence of providers warrant much attention. As Cuccaro and colleagues [104] elegantly demonstrated, there may be a clinician bias when diagnosing two children with exactly the same symptoms, depending on their socioeconomic background. There is indeed a great need for research in this area that guides truly accurate and universal assessment of ASDs.
Conclusions
ASD is a complex neurodevelopmental disorder that, for the majority of individuals, impacts the lifespan. Assessment of ASD is therefore not merely making a one-time diagnosis; the needs of children with ASD, as with all children, change as they develop over time, thus requiring monitoring and reevaluation throughout life. Clinicians need to not only have expertise in ASD symptomatology but also possess different sets of knowledge necessary at each stage of developmentfrom knowledge of early infant and toddler development, to understanding the complexities of school-age children, adolescents, and adults.
As the majority of adults with ASD struggle with the burdens of a multitude of associated symptomatology, the field is pushing for the earliest means of detection with the hope of ameliorating the potentially debilitating features that come with having a social disability. With this comes the push for investigations of new screening and diagnostic procedures that can effectively ascertain individuals across all racial, ethnic, and socioeconomic barriers, as well as the need for research on effective early interventions, because diagnosis and subsequent treatment must work in concert in order to truly benefit children and families. As the field moves forward, our hope is to maximize the potential of every individual with ASD so that assessment becomes more about ability rather than disability.
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